PBK/TOPK Is a Favorable Prognostic Biomarker Correlated with Antitumor Immunity in Colon Cancers
Immune checkpoint inhibitor therapy has proven efficacy in a subset of colon cancer patients featuring a deficient DNA mismatch repair system or a high microsatellite instability profile. However, there is high demand for more effective biomarkers to expand the colon cancer population responding to...
| Κύριοι συγγραφείς: | , , , , , |
|---|---|
| Μορφή: | Άρθρο |
| Γλώσσα: | English |
| Έκδοση: |
MDPI AG
2022-01-01
|
| Σειρά: | Biomedicines |
| Θέματα: | |
| Διαθέσιμο Online: | https://www.mdpi.com/2227-9059/10/2/299 |